Krzysztof Brzozka
Chief Tech/Sci/R&D Officer at RYVU THERAPEUTICS S.A.
Net worth: 3 M $ as of 2024-06-29
Profile
Krzysztof Brzozka is currently the Director at Ardigen SA and the Chief Scientific Officer & Executive VP at Ryvu Therapeutics SA. He has a graduate degree from Uniwersytet Jagiellonski, a doctorate degree from Ludwig-Maximilians-Universität München, and MBA degrees from Cracow University of Economics and Stockholm Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
RYVU THERAPEUTICS SA
1.16% | 2022-12-30 | 267,321 ( 1.16% ) | 3 M $ | 2024-06-29 |
Krzysztof Brzozka active positions
Companies | Position | Start |
---|---|---|
RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 2014-07-16 |
Ardigen SA
Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Director/Board Member | - |
Training of Krzysztof Brzozka
Uniwersytet Jagiellonski | Graduate Degree |
Ludwig-Maximilians-Universität München | Doctorate Degree |
Cracow University of Economics | Masters Business Admin |
Stockholm Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
RYVU THERAPEUTICS S.A. | Health Technology |
Private companies | 1 |
---|---|
Ardigen SA
Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Technology Services |
- Stock Market
- Insiders
- Krzysztof Brzozka